Viewing Study NCT06190093


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2026-02-25 @ 6:36 PM
Study NCT ID: NCT06190093
Status: COMPLETED
Last Update Posted: 2025-02-25
First Post: 2023-12-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)
Sponsor: Outlook Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ONS-5010-008
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators